Drug Type Small molecule drug |
Synonyms BAY 299, BAY-299, BAY299 |
Target |
Action inhibitors |
Mechanism BRPF2 inhibitors(bromodomain containing 1 inhibitors), TAF1 inhibitors(TATA-box binding protein associated factor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC25H23N3O4 |
InChIKeyOFWWWKWUCDUISA-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Discovery | China | 01 Dec 2021 | |
Neoplasms | Discovery | Germany | 11 May 2017 |